Endurant Capital Management’s Veracyte VCYT Stock Holding History

Endurant Capital Management’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-108,751	Closed	-$1.8M	–	73
2022 Q3	$1.8M	Buy	+108,751	New	+$2.45M	0.59%	34
2022 Q1	–	Sell	-87,343	Closed	-$3.6M	–	86
2021 Q4	$3.6M	Sell	87,343 -80,868	-48%	-$3.57M	0.87%	30
2021 Q3	$7.81M	Buy	168,211 +28,000	+20%	+$1.22M	1.78%	14
2021 Q2	$5.61M	Buy	+140,211	New	+$6M	1.54%	25

Other funds holding VCYT

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Endurant Capital Management's VCYT Position: Q4 2022 in Review

Endurant Capital Management sold out of Veracyte (VCYT) in Q4 2022, closing a stake of 108,751 shares — an estimated $1.8M sold.

Endurant Capital Management first reported a position in VCYT in Q2 2021 and held it in 4 quarters. The position peaked at $7.81M in Q3 2021. 223 funds tracked by Wall St. Rank hold VCYT as of Q4 2022.

Endurant Capital Management reported no remaining Veracyte position as of Q4 2022 after selling out during the quarter.
Endurant Capital Management sold 108,751 Veracyte shares in Q4 2022, an estimated $1.8M.
Endurant Capital Management first reported a position in Veracyte in Q2 2021 and held it in 4 quarters.
Endurant Capital Management's Veracyte position peaked at $7.81M in Q3 2021.
223 funds tracked by Wall St. Rank held Veracyte as of Q4 2022.

Based on Endurant Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.